Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Post time Half hour(s) ago

journal：Journal of Clinical Oncology

Authors：Johnathan K. Joffe; Fay H. Cafferty; Laura Murphy; Gordon J.S. Rustin; Syed A. Sohaib; Rhian Gabe; Sally P. Stenning; Elizabeth James; Dipa Noor; Simona Wade; Francesca Schiavone; Sarah Swift; Elaine Dunwoodie; Marcia Hall; Anand Sharma; Jeremy Braybrooke; Jonathan Shamash; John Logue; Henry H. Taylor; Ivo Hennig; Jeff White; Sarah Rudman; Jane Worlding; David Bloomfield; Guy Faust; Hilary Glen; Rachel Jones; Michael Seckl; Graham MacDonald; Thiagarajan Sreenivasan; Satish Kumar; Andrew Protheroe; Ramachandran Venkitaraman; Danish Mazhar; Victoria Coyle; Martin Highley; Tom Geldart; Robert Laing; Richard S. Kaplan; Robert A. Huddart;

Published date：2022-8-1

DOI：10.1200/jco.21.01199

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01199

Article link：https://doi.org/10.1200/jco.21.01199

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Other] Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST) Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)